The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 778K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

32 articles for M Jastrzebska-Wiesek


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
40
Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.EBI
Jagiellonian University Medical College
18
N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.EBI
Jagiellonian University Medical College
52
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.EBI
Jagiellonian University Collegium Medicum
22
Towards novel 5-HT7versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: design, synthesis, and antidepressant properties. Part II.EBI
Jagiellonian University Medical College
19
Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT1A receptor functional profile.EBI
Jagiellonian University Medical College
13
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors.EBI
Jagiellonian University Medical College
18
Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.EBI
Jagiellonian University Medical College
35
Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands.EBI
Jagiellonian University Medical College
4
Derivatives of pyrrolo[3,4-d]pyridazinone, a new class of analgesic agents.EBI
Wroclaw Medical University
36
Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents.EBI
Jagiellonian University
35
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease.EBI
Jagiellonian University
32
Dual 5-HT6/SERT ligands for mitigating neuropsychiatric symptoms of dementia exerting neuroprotection against amyloid-β toxicity, memory preservation, and antidepressant-like properties.EBI
Jagiellonian University Medical College
19
Hybrid molecules combining GABA-A and serotonin 5-HTEBI
Jagiellonian University Medical College
36
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HTEBI
Jagiellonian University Medical College
30
Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines.EBI
Jagiellonian University Medical College
27
Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia.EBI
Jagiellonian University Medical College
26
Multifunctional Arylsulfone and Arylsulfonamide-Based Ligands with Prominent Mood-Modulating Activity and Benign Safety Profile, Targeting Neuropsychiatric Symptoms of Dementia.EBI
Jagiellonian University Medical College
21
Chlorine substituents and linker topology as factors of 5-HTEBI
Jagiellonian University
38
Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HTEBI
Jagiellonian University Medical College
28
Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.EBI
Medical University of Warsaw
24
Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HTEBI
Jagiellonian University Medical College
41
Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).EBI
Jagiellonian University Medical College
35
Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HTEBI
Jagiellonian University Medical College
31
N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties.EBI
Jagiellonian University Medical College
22
Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HTEBI
Jagiellonian University
15
Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with α₁-adrenoceptor antagonistic properties.EBI
Jagiellonian University Medical College
1
MF-8, a novel promising arylpiperazine-hydantoin based 5-HTEBI
Jagiellonian University Medical College
12
Novel 5-HTEBI
Jagiellonian University Medical College
22
Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HTEBI
Jagiellonian University Medical College
41
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity.EBI
Jagiellonian University Medical College
15
The impact of the halogen bonding on DEBI
Jagiellonian University Medical College
22
The computer-aided discovery of novel family of the 5-HTEBI
Jagiellonian University